FDA approves trifluridine and tipiracil with bevacizumab for previously treated metastatic colorectal cancer

FDA approves trifluridine and tipiracil with bevacizumab for previously treated metastatic colorectal cancer

Source: FDA Center for Drug Evaluation and Research - What's New - August 2, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news